Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study

Abnormal adaptation over time of motor network recruitment in multiple sclerosis patients with fatigue

(2016) Maria A Rocca et al.   Multiple Sclerosis Journal

Abnormal adaptation over time of motor network recruitment in multiple sclerosis patients with fatigue

(2016) Maria A Rocca et al.   Multiple Sclerosis Journal

Andrographolide inhibits TNFα-induced ICAM-1 expression via suppression of NADPH oxidase activation and induction of HO-1 and GCLM expression through the PI3K/Akt/Nrf2 and PI3K/Akt/AP-1 pathways in human endothelial cells

(2014) Chia-Yang Lu et al.   BIOCHEMICAL PHARMACOLOGY

A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis

(2014) Ruth Ann Marrie et al.   Multiple Sclerosis Journal

Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study

(2014) Anat Achiron et al.   Multiple Sclerosis Journal

The Representation of Inflammatory Signals in the Brain – A Model for Subjective Fatigue in Multiple Sclerosis

(2014) Katrin Hanken et al.   Frontiers in Neurology

Management of Fatigue in Persons with Multiple Sclerosis

(2014) Fary Khan et al.   Frontiers in Neurology

Another armed CD4+T cell ready to battle hepatocellular carcinoma

(2013) Roniel Cabrera et al.   HEPATOLOGY

Sleep disorders in multiple sclerosis and their relationship to fatigue

(2013) Christian Veauthier et al.   SLEEP MEDICINE

Andrographis paniculata Extract (HMPL-004) for Active Ulcerative Colitis

(2012) William J Sandborn et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study

(2012) Vahid Shaygannejad et al.   NEUROLOGICAL RESEARCH

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-κB pathway

(2011) Ko-Chen Lee et al.   JOURNAL OF ETHNOPHARMACOLOGY

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

(2010) Kenneth F Schulz et al.   BMC Medicine

Neuroprotective effects of andrographolide in a rat model of permanent cerebral ischaemia

(2010) Su Jing Chan et al.   BRITISH JOURNAL OF PHARMACOLOGY

Correlation of self-assessed fatigue and alertness in multiple sclerosis

(2010) Nicholetta Weinges-Evers et al.   Multiple Sclerosis Journal

Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing—remitting multiple sclerosis

(2010) Massimiliano Calabrese et al.   Multiple Sclerosis Journal

Oxidative stress in the brain of nicotine-induced toxicity: protective role of Andrographis paniculata Nees and vitamin E

(2009) Subhasis Das et al.   Applied Physiology Nutrition and Metabolism

Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial

(2009) R. A. Burgos et al.   CLINICAL RHEUMATOLOGY

Multiple sclerosis: Human model for EAE?

(2009) Reinhard Hohlfeld   EUROPEAN JOURNAL OF IMMUNOLOGY

Modafinil effects in multiple sclerosis patients with fatigue

(2009) Rüdiger Lange et al.   JOURNAL OF NEUROLOGY

The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue

(2009) IK Penner et al.   Multiple Sclerosis Journal

Andrographolide reduces IL-2 production in T-cells by interfering with NFAT and MAPK activation

(2008) María D. Carretta et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways

(2008) J Sepulcre et al.   Multiple Sclerosis Journal